Enzo Biochem (ENZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ENZ | AMGN | VRTX | BMY | GILD |
| Company | Enzo Biochem | Amgen Inc | Vertex Pharmaceutic | Bristol-Myers Squibb Company | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NYSE | NASDAQ | NASDAQ | NYSE | NASDAQ |
| Open | 0.7110 | 262.18 | 403.14 | 56.93 | 92.62 |
| High | 0.7500 | 263.58 | 409.60 | 57.38 | 92.83 |
| Low | 0.7110 | 259.57 | 402.72 | 56.73 | 91.68 |
| Last | 0.7350 | 259.57 | 404.38 | 56.86 | 91.69 |
| Change | +0.0207 | -1.07 | +1.68 | +0.30 | -0.68 |
| % Change | +2.90% | -0.41% | +0.42% | +0.53% | -0.74% |
| Volume | 35,185 | 882,931 | 538,231 | 3,933,110 | 1,047,942 |
| 20-Day Average Volume | 213,429 | 3,680,337 | 1,848,139 | 10,920,707 | 6,671,448 |
| Previous Close | 0.7143 | 260.64 | 402.70 | 56.56 | 92.37 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.8648 | 267.38 | 437.18 | 57.34 | 92.40 |
| 20-Day Raw Stochastic | 15.08% | 28.09% | 27.16% | 40.89% | 51.73% |
| 20-Day Relative Strength | 32.49% | 32.40% | 34.90% | 50.77% | 51.74% |
| Weighted Alpha | -46.51 | -18.89 | -10.27 | +16.58 | +19.79 |
| Today's Opinion | 100% Sell | 88% Sell | 72% Sell | 72% Buy | 88% Buy |
| Previous Opinion | 100% Sell | 88% Sell | 72% Sell | 56% Buy | 88% Buy |
| Last Month's Opinion | 100% Sell | 72% Sell | 8% Sell | 100% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.32% since 12/24/24 | -1.40% since 12/24/24 | -0.87% since 12/24/24 | -1.37% since 12/24/24 | -2.08% since 12/24/24 |
| Low | 0.6901 on 12/27/24 | 258.50 on 12/30/24 | 399.06 on 12/30/24 | 55.93 on 12/31/24 | 91.72 on 12/30/24 |
| High | 0.7500 on 01/02/25 | 264.73 on 12/26/24 | 411.29 on 12/26/24 | 58.38 on 12/27/24 | 94.55 on 12/26/24 |
| 1-Month | |||||
| %Chg | -30.49% since 12/02/24 | -6.22% since 12/02/24 | -13.12% since 12/02/24 | -4.95% since 12/02/24 | -2.15% since 12/02/24 |
| Low | 0.6823 on 12/17/24 | 253.30 on 12/19/24 | 377.85 on 12/19/24 | 55.04 on 12/13/24 | 89.15 on 12/13/24 |
| High | 1.1287 on 12/03/24 | 281.38 on 12/03/24 | 476.46 on 12/10/24 | 60.09 on 12/03/24 | 94.65 on 12/11/24 |
| 3-Month | |||||
| %Chg | -34.75% since 10/02/24 | -18.43% since 10/02/24 | -12.44% since 10/02/24 | +5.97% since 10/02/24 | +8.56% since 10/02/24 |
| Low | 0.6823 on 12/17/24 | 253.30 on 12/19/24 | 377.85 on 12/19/24 | 51.31 on 10/15/24 | 83.98 on 10/04/24 |
| High | 1.1900 on 10/30/24 | 329.17 on 10/11/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| 6-Month | |||||
| %Chg | -30.49% since 07/02/24 | -16.08% since 07/02/24 | -14.59% since 07/02/24 | +40.84% since 07/02/24 | +34.50% since 07/02/24 |
| Low | 0.6823 on 12/17/24 | 253.30 on 12/19/24 | 377.85 on 12/19/24 | 39.35 on 07/05/24 | 66.01 on 07/05/24 |
| High | 1.2000 on 07/15/24 | 346.85 on 07/25/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 37,318 | 140,102,608 | 103,706,928 | 114,713,688 | 115,117,592 |
| Shares Outstanding, K | 52,244 | 537,533 | 257,529 | 2,028,177 | 1,246,266 |
| Annual Sales | 31,910,000 | 28,190,000,000 | 9,869,200,000 | 45,006,000,000 | 27,116,000,000 |
| Annual Net Income | -26,080,000 | 6,717,000,000 | 3,619,600,000 | 8,025,000,000 | 5,665,000,000 |
| Last Quarter Sales | 6,210,000 | 8,503,000,000 | 2,771,900,000 | 11,892,000,000 | 7,545,000,000 |
| Last Quarter Net Income | -3,380,000 | 2,830,000,000 | 1,045,400,000 | 1,211,000,000 | 1,253,000,000 |
| 60-Month Beta | 0.75 | 0.55 | 0.36 | 0.45 | 0.18 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.05 on 12/16/24 | 5.58 on 10/30/24 | 4.38 on 11/04/24 | 1.80 on 10/31/24 | 2.02 on 11/06/24 |
| Latest Earnings Date | 12/20/24 | 02/04/25 | 02/03/25 | 02/06/25 | 02/11/25 |
| Most Recent Dividend | 0.100 on 11/15/24 | 2.250 on 11/18/24 | N/A | 0.620 on 01/03/25 | 0.770 on 12/13/24 |
| Next Ex-Dividends Date | 11/15/24 | 02/14/25 | N/A | 01/03/25 | 12/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 13.49 | 0.00 | 47.91 | 20.77 |